BioWorld Asia

Oct. 19, 2005

ExonHit, BioMérieux Expand Union In Cancer Diagnostics

PARIS - ExonHit Therapeutics SA and BioMérieux extended and expanded their research collaboration for developing new blood-based diagnostics for the early detection of cancers. (BioWorld International) Read More

BioInvent Raising SEK160M In Discounted Rights Offering

Marijuana Brain Receptors May Help Slow Brain Aging

Trigen Brings In £18.2M Via Second Round For TGN255

Amgen Weighs In On Europe's Guidelines For Biosimilar Drugs

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for March 18, 2026.

Precision psychiatry beyond, or before, biomarkers

BioWorld

There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...

Keros reports beneficial effects of RKER-065 in ALS model

BioWorld Science

Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.

News in brief

BioWorld Asia

BioWorld Asia briefs for March 17, 2026

First-in-class POLG activator restores mtDNA across mutations

BioWorld Science

Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...